v3.22.1
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 21,606 $ 29,972
Restricted cash 203 203
Accounts receivable, less allowance of $2,236 and $2,154 as of March 31, 2022 and December 31, 2021, respectively 5,180 4,238
Inventory 14,611 12,929
Prepaid expenses and other current assets 2,183 2,012
Total current assets 43,783 49,354
Property, plant, and equipment, net 1,244 1,067
Goodwill 2,926 2,926
Right of use asset 2,058 1,717
Other assets 231 220
Total assets 50,242 55,284
Current liabilities:    
Accounts payable 4,643 3,309
Accrued liabilities 6,027 8,276
Deferred revenue, current portion 2,442 2,259
Total current liabilities 13,112 13,844
Deferred revenue 303 329
Warranty accrual 512 521
Non current term loans, net of discount 13,666 13,603
Non current operating lease liability 1,662 1,449
Other liabilities 387 330
Total liabilities 29,642 30,076
Commitments and contingencies — Note 11
Redeemable preferred stock:    
Series G Preferred stock, par value $0.001 per share; 180 shares authorized, 6 shares issued and outstanding as of March 31, 2022
Total redeemable preferred stock
Stockholders' equity:    
Series F Preferred stock, par value $0.001 per share; 18 shares authorized, 0 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively 0 34
Common stock, par value $0.001 per share; 180,000 shares authorized, 6,176 and 6,149 shares issued and 6,174 and 6,147 shares outstanding as of March 31, 2022 and December 31, 2021, respectively 155 154
Additional paid-in-capital 293,419 293,177
Accumulated other comprehensive loss (664) (623)
Accumulated deficit (272,310) (267,534)
Total stockholders' equity 20,600 25,208
Total liabilities, redeemable preferred stock and stockholders' equity $ 50,242 $ 55,284

Source